Access info on COVID testing, vaccination, visitor policy, hospitalization data, and FAQs.

toggle mobile menu Menu
toggle search menu

Site Navigation



Monoclonal Antibody Treatment for COVID-19

Potential Help if You're Sick

Monoclonal antibodies are human-made proteins that act like natural antibodies. When the COVID-19 virus gets into your body, it enters healthy cells and starts to make more virus. This can make you sick. Antibodies block the virus from getting into your cells, which can limit the illness. 

Monoclonal antibodies work best if administered as early as possible (within 10 days of onset of symptoms). 

Receiving treatment greatly reduces the risk of hospitalization for those at moderate-to-high risk. Several locations at St. Luke's are currently providing either casirivimab-imdevimab (Regen-Cov) or bamlanivimab-etesevimab, both of which have been granted emergency use authorization approval from the FDA. 

Please contact your primary care provider for a referral if you feel you're a candidate for this treatment. Most St. Luke’s emergency departments cannot provide monoclonal antibody treatment

Conditions and Factors Placing Patients at Higher Risk for Severe COVID-19

  • Age (65 or older)
  • Obesity or being overweight (a BMI of 25 or higher)
  • Pregnancy
  • Chronic kidney disease
  • Diabetes
  • Immunosuppressive disease or immunosuppressive treatment
  • Cardiovascular disease (including congenital heart disease) or hypertension
  • Chronic lung diseases (e.g., chronic obstructive pulmonary disease, asthma [moderate-to-severe], interstitial lung disease, cystic fibrosis, and pulmonary hypertension)
  • Sickle cell disease
  • Neurodevelopmental disorders (e.g., cerebral palsy) or other complex conditions (e.g., genetic or metabolic syndromes and severe congenital anomalies)
  • Having a medical-related technological dependence (e.g., tracheostomy, gastrostomy, or positive pressure ventilation unrelated to COVID-19)

What to Expect

How will I receive the monoclonal antibodies?

  • Monoclonal antibodies are given either through a vein (intravenous or IV) or injected in the tissue just under the skin (subcutaneous injections). The subcutaneous injections are given as four separate injections, usually in the abdomen.

How long will it take?

  • The treatment is given in a single visit. You will need to be monitored for 1 hour after the medication is given. If you are receiving an intravenous infusion, the infusion will take 20 to 50 minutes or longer.

The type of medication you will be scheduled for will depend on your location and appointment availability.

How can I make an appointment?

Please contact your primary care provider. Treatment requires a provider’s order. Once the St. Luke’s Infusion Services Pharmacy receives your order, they will contact you with an appointment time and further instructions. If you're a St. Luke's patient and have tested positive for COVID-19, but do not have a primary care provider or need to connect with a provider urgently, you can now access virtual urgent care. You will need to login to your MyChart account or create an account if you do not have one. 

  • Baker City: St. Luke's Clinic – Eastern Oregon Medical Associates
  • Fruitland: St. Luke's Fruitland Medical Plaza
  • Meridian: St. Luke's Clinic – COVID Antibody Treatment
  • Twin Falls: St. Luke's Magic Valley Medical Center

To reach a scheduler, please call (208) 706-0646. Providers outside St. Luke’s can submit orders by faxing our monoclonal antibody order form to (208) 706-5136.